Abu Dhabi: New Cutting-edge Animal Vaccine Manufacturing Facility

  • Publish date: Tuesday، 05 April 2022
Abu Dhabi: New Cutting-edge Animal Vaccine Manufacturing Facility
Related articles
UAE to Boost Manufacturing in Defence Sector
Abu Dhabi: COVID-19 Vaccines, PCR Tests to be Provided in Pharmacies
Abu Dhabi: 105,300 Traffic Fines For Not Paying Attention to Roads

Abu Dhabi’s ADQ will establish a new animal health platform in the capital which will initially comprise a cutting-edge animal vaccine manufacturing facility and a complex with two state-of-the-art animal hospitals.

Once operational, it will provide veterinary services for horses and camels while producing the most technologically advanced animal vaccines serving the Middle East and Africa (MEA) region.

Fahad Al Qassim, Executive Director, Healthcare & Life Sciences Portfolio at ADQ, said, "Leveraging our healthcare and life sciences expertise, we have identified an opportunity to create an adjacent platform in animal health. By creating a joint venture with E20, we will capitalise on Abu Dhabi's strong market potential for animal vaccine production and maintaining the health and welfare of prized animals, such as horses and camels."

Sultan Al Jaberi, CEO of E20 Investment Limited, stated, "Together with ADQ, we will bring world-class vaccine technology to the UAE and join hands with our partner to foster local production and serve lucrative markets in the MENA region and beyond."